Optimizing Molecular-Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways

The hallmarks of ovarian cancer encompass the development of resistance, disease recurrence and poor prognosis. Ovarian cancer cells express gene signatures which pose significant challenges for cancer drug development, therapeutics, prevention and management. Despite enhancements in contemporary tu...

Descripción completa

Detalles Bibliográficos
Autor principal: Hiss, Donavon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3306947/
https://www.ncbi.nlm.nih.gov/pubmed/22481932
http://dx.doi.org/10.1155/2012/737981

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3306947/
https://www.ncbi.nlm.nih.gov/pubmed/22481932
http://dx.doi.org/10.1155/2012/737981

Ejemplares similares